국내외 동향 읽기 페이지
제목 | [보고서] [한국보건산업진흥원] 바이오의약품 산업 분석 및 정책 연구 201231 |
---|---|
|
|
첨부파일 | |
한국보건산업진흥원에서 발간한 "바이오의약품 산업 분석 및 정책 연구"보고서 입니다.
<목 차> 제1장. 서 론 ························································································1 1. 연구의 배경 및 목적 ········································································3 2. 연구 내용 및 방법 ············································································5 제2장. 바이오의약품 개념 및 정의 ····················································9 1. 의약품 정의 및 분류 ······································································11 2. 바이오의약품 특성 및 유형 ···························································19 제3장. 글로벌 바이오의약품 산업 및 정책 동향 ·····························31 1. 글로벌 바이오의약품 산업 동향 ···················································33 2. 글로벌 바이오의약품 연구개발 동향 ············································68 3. 글로벌 바이오의약품 정책 동향 ·················································109 4. 소결 ································································································128 제4장. 국내 바이오의약품 산업 및 정책 동향 ······························131 1. 국내 바이오의약품 산업 현황 ·····················································133 2. 국내 바이오의약품 연구개발 동향 ·············································150 3. 국내 바이오의약품 산업 정책 동향 ···········································193 4. 소결 ································································································206 제5장. 국내 바이오의약품 산업 경쟁력 분석 ································211 1. 조사 개요 ·······················································································213 2. 조사 결과 ·······················································································214 제6장. 결론 및 정책 제언 ······························································225 1. 연구 결과 ·······················································································227 2. 정책 제언 ·······················································································230 ▪ 참고문헌 ·····················································································243 ▪ 부 록 ·····················································································251 【부록】 전문가 델파이 조사표 ··························································253
한국보건산업진흥원에서 발간한 "바이오의약품 산업 분석 및 정책 연구"보고서 입니다.
<목 차> 제1장. 서 론 ························································································1 1. 연구의 배경 및 목적 ········································································3 2. 연구 내용 및 방법 ············································································5 제2장. 바이오의약품 개념 및 정의 ····················································9 1. 의약품 정의 및 분류 ······································································11 2. 바이오의약품 특성 및 유형 ···························································19 제3장. 글로벌 바이오의약품 산업 및 정책 동향 ·····························31 1. 글로벌 바이오의약품 산업 동향 ···················································33 2. 글로벌 바이오의약품 연구개발 동향 ············································68 3. 글로벌 바이오의약품 정책 동향 ·················································109 4. 소결 ································································································128 제4장. 국내 바이오의약품 산업 및 정책 동향 ······························131 1. 국내 바이오의약품 산업 현황 ·····················································133 2. 국내 바이오의약품 연구개발 동향 ·············································150 3. 국내 바이오의약품 산업 정책 동향 ···········································193 4. 소결 ································································································206 제5장. 국내 바이오의약품 산업 경쟁력 분석 ································211 1. 조사 개요 ·······················································································213 2. 조사 결과 ·······················································································214 제6장. 결론 및 정책 제언 ······························································225 1. 연구 결과 ·······················································································227 2. 정책 제언 ·······················································································230 ▪ 참고문헌 ·····················································································243 ▪ 부 록 ·····················································································251 【부록】 전문가 델파이 조사표 ··························································253
|
|
이전글 ▲ | [글로벌 보건산업 동향 Vol.382] 미국 헬스케어산업, '21년 주요 정책현안 점검 210322 |
다음글 ▼ | [글로벌 보건산업 동향 Vol.383] 뇌과학, 새로운 시장의 확대와 인간의 웰빙에 공헌 210329 |